These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
39 related articles for article (PubMed ID: 1788290)
1. Pertussis toxin increases sensitivity to the lethal effect of morphine in mice. Campos-Sepúlveda AE; García-Sainz JA; Rodríguez R; Luján M Proc West Pharmacol Soc; 1991; 34():23-5. PubMed ID: 1788290 [No Abstract] [Full Text] [Related]
2. Intracerebroventricular pertussis toxin enhances sensitivity to N-methyl-D-aspartate-induced seizures in mice. Durcan MJ; Morgan PF Eur J Pharmacol; 1991 May; 197(2-3):209-11. PubMed ID: 1655474 [TBL] [Abstract][Full Text] [Related]
3. Intracerebroventricular pertussis toxin enhances sensitivity to chemical convulsants and decreases the protective efficacy of carbamazepine in mice. Korolkiewicz R; Kleinrok Z; Mlynarczyk M Pharmacol Res; 1996 Mar; 33(3):211-5. PubMed ID: 8880893 [TBL] [Abstract][Full Text] [Related]
4. Increased levels of active pertussis toxin may aid a pertussis vaccine to pass the mouse body weight gain test. Horiuchi Y; Takahashi M; Asada S; Ishida S Biologicals; 1994 Sep; 22(3):243-8. PubMed ID: 7811458 [TBL] [Abstract][Full Text] [Related]
5. Pertussis toxin inhibits the antinociceptive action of morphine in the rat. Parenti M; Tirone F; Giagnoni G; Pecora N; Parolaro D Eur J Pharmacol; 1986 May; 124(3):357-9. PubMed ID: 3732384 [TBL] [Abstract][Full Text] [Related]
6. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse. Tseng LF; Collins KA J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973 [TBL] [Abstract][Full Text] [Related]
7. Chronic morphine administration and in vivo pertussis toxin treatment induce hyperalgesia and enhance 3H-nitrendipine binding. Inoki R; Ohnishi T; Saito K; Maeda S; Matsumoto K; Sakuda M Prog Clin Biol Res; 1990; 328():469-72. PubMed ID: 2106149 [No Abstract] [Full Text] [Related]
8. Collaborative study for the establishment of a European Pharmacopoeia Biological Reference Preparation for pertussis toxin--Part 1. Dobbelaer R; Daas A; Esposito-Farese ME Pharmeuropa Spec Issue Biol; 2001 Aug; 2001(1):15-23. PubMed ID: 11705098 [No Abstract] [Full Text] [Related]
9. Modulation of cannabinoid-induced antinociception after intracerebroventricular versus intrathecal administration to mice: possible mechanisms for interaction with morphine. Welch SP; Thomas C; Patrick GS J Pharmacol Exp Ther; 1995 Jan; 272(1):310-21. PubMed ID: 7815346 [TBL] [Abstract][Full Text] [Related]
10. The role of pertussis toxin and betamethasone on lymphocyte accumulation in the lungs of mice. Torre D; Maggiolo F; Quadrelli C; Di Natale F Ann Sclavo Collana Monogr; 1986; 3(1-2):337-46. PubMed ID: 3426878 [No Abstract] [Full Text] [Related]
12. Multiple T and B cell epitopes in the S1 subunit ("A"-monomer) of the pertussis toxin molecule. Oksenberg JR; Ko C; Judd AK; Lim M; Kent A; Schoolnik GK; Steinman L J Immunol; 1989 Dec; 143(12):4227-31. PubMed ID: 2480389 [TBL] [Abstract][Full Text] [Related]
13. Pertussis toxin inhibits morphine-induced release of adenosine from the spinal cord. Sawynok J; Sweeney M; Nicholson D; White T Prog Clin Biol Res; 1990; 328():397-400. PubMed ID: 2304959 [No Abstract] [Full Text] [Related]
14. Acellular pertussis vaccines: neutralization by immune sera of the lethality of pertussis toxin and viable Bordetella pertussis for chick embryos. Calver GA Biologicals; 1999 Jun; 27(2):143-7. PubMed ID: 10600203 [TBL] [Abstract][Full Text] [Related]
15. Cyclic AMP levels in lung and spleen tissue of mice treated with pertussis toxin. Torre D; Pugliese A; Quadrelli C; Speranza F; Sampietro C Microbiologica; 1989 Jan; 12(1):29-33. PubMed ID: 2541317 [TBL] [Abstract][Full Text] [Related]
16. Intracerebroventricular treatment of mice with pertussis toxin induces hyperalgesia and enhances 3H-nitrendipine binding to synaptic membranes: similarity with morphine tolerance. Ohnishi T; Saito K; Maeda S; Matsumoto K; Sakuda M; Inoki R Naunyn Schmiedebergs Arch Pharmacol; 1990; 341(1-2):123-7. PubMed ID: 2107404 [TBL] [Abstract][Full Text] [Related]
17. [Features of expression of the pertussis toxin operon under the control of its own and heterologous promotors in Bordetella bronchiseptica cells]. Govorun VM; Ivanova VF; Kirillov MIu; Klitsunova NV; Nechaeva EV; Siniashina LN; Shumakov IuL; Karataev GI Mol Gen Mikrobiol Virusol; 1993; (2):21-7. PubMed ID: 8515746 [TBL] [Abstract][Full Text] [Related]
18. Central pertussis toxin abolishes the intestinal inhibition induced by intracerebroventricular morphine. Massi P; Patrini G; Rubino T; Vicinanza E; Parolaro D Pharmacol Res; 1989; 21 Suppl 1():69-70. PubMed ID: 2517341 [No Abstract] [Full Text] [Related]
19. Toxicity tests on native and recombinant Bordetella pertussis adenylate cyclase toxin preparations. Hormozi K; Parton R; Coote J Dev Biol Stand; 1999; 101():147-54. PubMed ID: 10566788 [TBL] [Abstract][Full Text] [Related]
20. [Trial of pertussis toxin activity in vitro on CHO cells]. Spitsyn SV; Drobyshevskaia EI; Gureeva AA Zh Mikrobiol Epidemiol Immunobiol; 1987 Jun; (6):60-3. PubMed ID: 3630484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]